Xeris Pharmaceuticals | 净收入



Net Income 更改 日
Adcock Ingram Holdings ZAR 389.71M 19.87M 2024-12
Celltrion KRW 108.67B 127.98B 2025-03
Cspc Pharmaceutical CNY 1.48B 927.97M 2025-03
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Divis Laboratories Ltd 5.45B 1.17B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Kangmei Pharma CNY 8.51M 4.95M 2025-03
Knight Therapeutics CAD 85K 2.03M 2024-09
Laboratorios Farma EUR 92.54M 63.16M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 304K 15.32M 2024-12
Neuren Pharmaceuticals AUD 134.03M 126.01M 2024-12
Organigram Holdings CAD -22957000 17.52M 2024-12
Pacira USD -4847000 9.66M 2025-06
Perrigo USD -8400000 2M 2025-06
Pharma Mar EUR 23.37M 27.32M 2025-06
Qiagen NV USD 96.25M 5.49M 2025-06
Sartorius EUR 32.5M 15.9M 2025-06
Sino Biopharmaceutical CNY 482.67M 2.53B 2024-12
Supernus Pharmaceuticals USD 22.5M 34.33M 2025-06
Tilray USD -85342000 46.18M 2024-11
Zz Pientze Pharmaceu 999.78M 709.47M 2025-03


Xeris Pharmaceuticals 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.